A detailed history of Woodstock Corp transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Woodstock Corp holds 29,211 shares of LGND stock, worth $3.35 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
29,211
Previous 29,111 0.34%
Holding current value
$3.35 Million
Previous $2.45 Million 19.33%
% of portfolio
0.28%
Previous 0.25%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$82.7 - $110.11 $8,270 - $11,011
100 Added 0.34%
29,211 $2.93 Million
Q2 2024

Jul 08, 2024

SELL
$68.53 - $87.91 $68,530 - $87,910
-1,000 Reduced 3.32%
29,111 $2.45 Million
Q4 2023

Jan 08, 2024

SELL
$49.57 - $72.63 $200,708 - $294,078
-4,049 Reduced 11.85%
30,111 $2.15 Million
Q3 2023

Oct 10, 2023

SELL
$58.86 - $72.67 $743,696 - $918,185
-12,635 Reduced 27.0%
34,160 $2.05 Million
Q2 2023

Jul 07, 2023

SELL
$69.53 - $79.33 $403,899 - $460,827
-5,809 Reduced 11.04%
46,795 $3.37 Million
Q1 2023

Apr 06, 2023

SELL
$65.67 - $77.08 $158,264 - $185,762
-2,410 Reduced 4.38%
52,604 $3.87 Million
Q4 2022

Jan 10, 2023

SELL
$61.72 - $96.74 $412,289 - $646,223
-6,680 Reduced 10.83%
55,014 $0
Q3 2022

Oct 11, 2022

SELL
$0.01 - $107.56 $22 - $237,277
-2,206 Reduced 3.45%
61,694 $5.31 Million
Q2 2022

Jul 11, 2022

SELL
$74.52 - $117.06 $11,178 - $17,559
-150 Reduced 0.23%
63,900 $5.7 Million
Q1 2022

Apr 07, 2022

SELL
$94.99 - $151.56 $438,473 - $699,600
-4,616 Reduced 6.72%
64,050 $7.21 Million
Q3 2021

Oct 05, 2021

SELL
$102.33 - $144.73 $11,256 - $15,920
-110 Reduced 0.16%
68,666 $9.57 Million
Q1 2021

Apr 05, 2021

SELL
$99.52 - $215.83 $70,360 - $152,591
-707 Reduced 1.02%
68,776 $10.5 Million
Q4 2020

Jan 06, 2021

BUY
$80.55 - $106.05 $1,611 - $2,121
20 Added 0.03%
69,483 $6.91 Million
Q3 2020

Oct 02, 2020

SELL
$89.56 - $126.72 $130,757 - $185,011
-1,460 Reduced 2.06%
69,463 $6.62 Million
Q2 2020

Jul 07, 2020

BUY
$68.28 - $123.65 $7,237 - $13,106
106 Added 0.15%
70,923 $7.93 Million
Q1 2020

Apr 03, 2020

SELL
$63.37 - $107.88 $42,584 - $72,495
-672 Reduced 0.94%
70,817 $5.15 Million
Q4 2019

Jan 13, 2020

BUY
$96.94 - $113.59 $23,362 - $27,375
241 Added 0.34%
71,489 $7.46 Million
Q3 2019

Oct 02, 2019

BUY
$86.25 - $120.16 $5,606 - $7,810
65 Added 0.09%
71,248 $7.09 Million
Q2 2019

Jul 03, 2019

BUY
$107.38 - $129.34 $46,173 - $55,616
430 Added 0.61%
71,183 $8.13 Million
Q1 2019

Apr 05, 2019

BUY
$105.93 - $142.47 $105,294 - $141,615
994 Added 1.42%
70,753 $8.89 Million
Q4 2018

Jan 08, 2019

BUY
$128.36 - $272.13 $391,626 - $830,268
3,051 Added 4.57%
69,759 $9.47 Million
Q3 2018

Oct 03, 2018

SELL
$211.18 - $274.49 $250,881 - $326,094
-1,188 Reduced 1.75%
66,708 $18.3 Million
Q2 2018

Jul 23, 2018

SELL
$150.77 - $207.98 $162,077 - $223,578
-1,075 Reduced 1.56%
67,896 $14.1 Million
Q1 2018

Apr 19, 2018

SELL
$138.63 - $182.62 $24,537 - $32,323
-177 Reduced 0.26%
68,971 $11.4 Million
Q4 2017

Jan 24, 2018

BUY
$128.36 - $147.04 $27,340 - $31,319
213 Added 0.31%
69,148 $9.47 Million
Q3 2017

Oct 06, 2017

BUY
$120.91 - $137.94 $8.33 Million - $9.51 Million
68,935
68,935 $9.39 Million

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.94B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Woodstock Corp Portfolio

Follow Woodstock Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodstock Corp, based on Form 13F filings with the SEC.

News

Stay updated on Woodstock Corp with notifications on news.